WO2022076122A1 - Procédés, systèmes et produits-programmes informatiques pour calculer des signaux métakg pour des régions ayant de multiples ensembles de caractéristiques optiques - Google Patents

Procédés, systèmes et produits-programmes informatiques pour calculer des signaux métakg pour des régions ayant de multiples ensembles de caractéristiques optiques Download PDF

Info

Publication number
WO2022076122A1
WO2022076122A1 PCT/US2021/049608 US2021049608W WO2022076122A1 WO 2022076122 A1 WO2022076122 A1 WO 2022076122A1 US 2021049608 W US2021049608 W US 2021049608W WO 2022076122 A1 WO2022076122 A1 WO 2022076122A1
Authority
WO
WIPO (PCT)
Prior art keywords
metakg
signal
interest
region
calculating
Prior art date
Application number
PCT/US2021/049608
Other languages
English (en)
Inventor
Thomas Bruce FERGUSON Jr.
Sunghan Kim
William Hempstead
Cheng Chen
Original Assignee
East Carolina University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/062,989 external-priority patent/US11553844B2/en
Application filed by East Carolina University filed Critical East Carolina University
Priority to CA3196709A priority Critical patent/CA3196709A1/fr
Publication of WO2022076122A1 publication Critical patent/WO2022076122A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
    • A61B5/004—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A61B5/0044—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
    • A61B5/7214—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts using signal cancellation, e.g. based on input of two identical physiological sensors spaced apart, or based on two signals derived from the same sensor, for different optical wavelengths
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
    • G02B27/48—Laser speckle optics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/20—ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2576/00—Medical imaging apparatus involving image processing or analysis

Definitions

  • the inventive concept relates generally to visualization of organs and/or tissue and, more particularly, to determining blood flow and perfusion parameters in a sample.
  • Blood flow and perfusion m tissue/organs are defined by the amount of blood transferred per unit time over a 2-dimensional area or in a 3 -dimensional structure.
  • Blood flow generally relates to volume of flow/imit time in conduits larger than the arteriolar level (macrovascular level).
  • Perfusion typically refers to the blood flow in the microyascular level, w ith no current parameters forquantification with non-invasive technologies. Direct measurement and quantification of blood flow and perfusion in real time is still being de veloped.
  • Fluid velocity is linear flow demonstrating the direction and magnitude of flow, but does not directly quantify flow in either the microvascular or macrovascular levels.
  • LD1 Laser Doppler Imaging
  • LSI Laser Speckle Imaging
  • Some embodiments of thepresent inventive concept provide methods for calculating a MetaKG signal
  • the method includes -Illuminating a region of interest in a sample with at least one light source, wherein the ; light source is a near-infrared (NIR) light source and/or a visible light source; acquiring images of the region of interest; processing the acquired images to obtain metadata associated with the acquired images; and calculating the MetaKG signal from the metadata associated with the acquired images.
  • NIR near-infrared
  • the MetaKG signal may be derived from raw images or from perfusion images.
  • the: method may further include acquiring blood flow and perfusion data using the calculated MetaKG signal.
  • Calculating the MetaKG signal may further include generating the MetaKG signal from the acquired images by processing the acquired images to obtain contrast images and calculating average contrast intensity of the contrast Images versus time in the region of interest.
  • the method may further include calculating at least one of heart rate and pulsatility information from: the average intensity versus time in the region of interest by analyzing a frequency component of the average intensity versus time.
  • the method may further include differentiating between abnormal and normal tissue based on frequency component of the average intensity versus time; and indicating a degree of abnormality related to an underlying physiological response ⁇ [0009]
  • the method may further include extracting heart rate variability (HRV) information from the heart rate calculated from the average contrast intensity versus time in the region of interest.
  • HRV heart rate variability
  • the method may further include changing configuration of the region of interest; and generating a two dimensional heart rate map of a region of interest in a field of view.
  • Changing the configuration of the region of interest may include changing at least one of the size and the location ofthe region of interest.
  • the sample may be one of tissue and an organ.
  • calculating the MetaKG signal may include calculating the MetaKG signal using average intensity of speckle contrast images.
  • At least one Hempdynamic Status Parameter may be determined including Heart Rate (HR); heart rate variability (HRV); R-to-R interval (RRI); RRI Standard Deviation (RRISD); systolic Blood Pressure threshold (SBt); rate x pressure product (RPR); instantaneous perfusion in systole and diastole; frequency analysis and time-frequency analysis of a perfusion curve; and contractility Index including slope of the perfusion curve based on the calculated MetaKG.
  • HR Heart Rate
  • HRV heart rate variability
  • RRI R-to-R interval
  • RRISD RRI Standard Deviation
  • SBt systolic Blood Pressure threshold
  • RPR rate x pressure product
  • instantaneous perfusion in systole and diastole frequency analysis and time-frequency analysis of a perfusion curve
  • contractility Index including slope of the perfusion curve based on the calculated MetaKG.
  • At least one Hemodynamic Status Parameter may be determined including tissue oxygen content, hemoglobin content, and temperature based on the calculated MetaKG signal.
  • Some embodiments of the present inventive concept provide computer systems for calculating a MetaKG signal.
  • the systems include a processor; and a memory coupled to the processor and comprising computer readable pro gram code that when executed by the processor causes the processor to perform operations including illuminating a region of interest in a sample with at least one light source, wherein the light source is a near-infrared (NIR) light source and/or a visible light source; acquiring images of the region of interest; processing the acquired images to obtain metadata associated with the acquired images: and calculating the MetaKG signal from the metadata associated with the acquired Images.
  • NIR near-infrared
  • FIG. 10 Further embodiments of the present inventive concept provide computer program products for calculating a MetaKG signal.
  • the computer program products including a non- transitory computer readable storage medium having computer readable program code embodied in the medium, the computer readable program code including computer readable program -code to illuminate a region of interest in a sample with at least one light source, wherein the light source is a near-infrared (NIR) light source and/or a visible light source; computer readable, program code to acquire images of the region of interest; computer readable program code to process the acquired images to obtain metadata associated with the acquired images; and computer readable program code to calculate the MetaKG signal from the metadata associated with die acquired images.
  • NIR near-infrared
  • Still further embodiments of the present inventive concept provide methods of removing movement-related artifacts from a MetaKG signal using dual wavelength light sources.
  • the methods include illuminating a region of interest in a sample with a near-infrared (NIR) light source and a visible light (VL) source; acquiring two sets of images of the region of interest each corresponding to one of the NIR light source and the VL source; processi ng the two sets of images to obtain NIR-metadata and VL-metadata; calculating a NIR MetaKG and aVL MetaKG from the NIR- metadata and the VL metadata, respectively ; extracting a movement-related common, signal component from the NIR MetaKG and the VL MetaKG: and calculating a noise- free MetaKG by cancelling out the movement-related common signal component from the NIR MetaKG.
  • NIR near-infrared
  • VL visible light
  • calculating the noise-free MetaKG may include removing noise due to a motion artifact, where the noise due to the motion artifact includes respiratory activity.
  • FIG. 1 For embodiments of the present inventi ve concept, further embodiments of the present inventi ve concept provide a method for calculating a MetaKG signal.
  • the method includes illuminating a region of interest -in a sample with at least one multi-wavelength light source.
  • the region of interest includes a sample portion and a background portion and the multi- wavelength light source is a near-infrared (NIR) light source and/or a visible light source.
  • NIR near-infrared
  • Multi-spectral images of the region of interest are acquired using a multi-wavelength camera.
  • the acquired multi -spectral images are processed to obtain metadata associated with the acquired multi -spectral images.
  • a background MetaKG signal is calculated for the background portion of the region of interest from the metadata associated with the acquired multi- spectral Images.
  • a MetaKG signal for the region of Interest is calculated from the metadata associated with the acquired multi-spectral images.
  • the calculated MetaKG signal for the region of interest is adjusted using the calculated background MetaKG signal to provide a final adjusted MetaKG signal.
  • Calculating the background MetaKG signal and the MetaKG signal for the region of interest includes calculating a multi-spectral MetaKG signal using multi-spectral signal processing to remove motion artifacts and improve signal quality.
  • Calculating the multi-spectral MetaKG signal comprises calculating a residual MetaKG wherein is : raw or speckle contrast images of a first wavelength. is raw or speckle contrast images of a second wavelength; .a, b and c are parameters for normalization; and M and N are a number of pixels along x and y axes. respectively.
  • Still further embodiments of the present inventive concept provide a method for calculating a MetaKG signal for a region of interest in a sample.
  • the method includes illuminating a region of interest in a sample with a light source having a single wavelength.
  • the region of interest has a sample portion having a first set of optical characteristics and a background portion having a second set of optical characteristics.
  • Images of the region of interest are acquired.
  • the acquired images- of the region of interest are processed to obtain metadata associated with the acquired images.
  • a MetaKG signal for the region of interest from tire metadata associated with the acquired images is calculated.
  • a background MetaKG signal from the metadata associated with fee background portion of the region of interest is calculated.
  • the calculated MetaKG signal for fee region of interest is adjusted using the calculated background MetaKG to provide a final adjusted MetaKG signal for the region of interest
  • Fig. 1 is a block diagram of a system in accordance with some embodiments of the present inventive concepts).
  • Figs. 2 A through 2C are graphs illustrating average intensity vs. time in a multiwavelength imaging technology in accordance with some embodiments of the present inventive concept.
  • Figs. 3Athrough 3C are graphs illustrating average intensity vs. time in a multiwavelength Imaging technology having respiration contamination removed in accordance with some embodiments of the present .inventive concept.
  • Figs.. 4 A through 4C are a series of Laser Speckle images of the heart.
  • Fig. 5 is a graph illustrating average intensity v. time representing the metaKG signal in accordance with embodiments of the present inventive concept.
  • Figs. 6A-C is a series -ofLaser Speckle images of the heart during a systolic phase.
  • Fig. 7 is a graph: illustrating average intensity v. time representing the metaKG signal in accordance with embodiments of the present inventive concept.
  • Figs. 8A-C is a series of Laser Speckle images of the heart during diastolic phase
  • Fig. 8D is a graph illustrating average intensity v, time representing the metaKG signal in accordance with embodiments of the present inventive concept.
  • Fig. 9 A is an image illustrating one frame of raw image data sequence In diastolic phase.
  • Fig. 9B is an image illustrating one frame of raw image data sequence in systolic phase.
  • Fig. 9C is a graph of average intensity vs. time curve as the metaKG signal in accordance with some embodiments of the present inventive concept
  • Fig. 10A is an image illustrating one frame from raw image data sequence.
  • Fig. I0B is an image illustratmg the blood velocity distribution in the fingers.
  • Fig. 10C is a graph of average intensity vs. time curve as the metaKG signal in accordance with some embodiments of the present inventive concept.
  • Fig. 11 A is an Image illustrating LSI-analyzed velocity map of perfusion to two fingers of left hand and two fingers o f ri ght hand.
  • Fig. 1 IB is a graph illustrating average intensity vs. time curve of 12 seconds (60: fps) image sequence of two fingers of left hand and two fingers of right hand (aggregate from all four fingers) of Fig. 11 A.
  • Fig. 11 C is a graph illustrating standard EKG and peripheral oxygen saturationinstallatility data acquired simultaneous with the image sequence in accordance: with embodiments of the present inventive concept.
  • Figs. 12A and 12B illustrate the two left: fingers cf Fig. 11 A and the associated average intensity vs. time curve of the two left fingers.
  • Figs. 12C and 12D illustrate the two right fingers of Fig. 11 A and the associated average intensity vs. time curve of the two right fingers.
  • Figs. 12E through 12H are graphs illustrating frequency domain analyses of the average intensity vs. time curves for both the left (E and F) and right (G and H) fingers,
  • Fig, 13 A is an image illustating LSI-analyzed velocity map of perfusion to two fingers of lefthand and two fingers of right hand.
  • IG0431 Fig. 13B is a graph illustrating average intensity vs. time curve of 12 seconds (60 fps) image sequence of two fingers of left hand and two fingers of right hand (aggregate from all four fingers) of Fig. 11 A.
  • Fig. 13C is a graph illustrating standard EKG and peripheral oxygen saturationinstallatility data acquired simultaneous with the image sequence in accordance with embodiments of the present inventive concept.
  • Figs. 14A and 14B illustrate the two left fingers and the associated average intensity vs. time curve of the two left fingers.
  • Figs. 14C and 14D illustrate the two right fingers and the associated average intensity vs. time curve of the two right fingers.
  • Fig. 14E through 14H are graphs illustrating frequency domain analy ses of the average intensity vs. time curves for both the left (E and F) and right (G and.H) fingers.
  • Fig. 15A Is an image illustrating LSI-analyzed velocity map of perfusion to two fingers of left hand and two fingers of right hand.
  • Fig. 15B is a graph illustrating average intensity vs. time curve of 12 seconds (60 fps) image sequence of two fingers of left hand and two fingers of right hand (aggregate from all four fingers).
  • Fig. 15C is a graph illustrating standard EKG and peripheral oxygen saturationinstallatility data acquired simultaneous with the image sequence in accordance with embodiments of the present inventive concept.
  • Figs- ISA and 16B illustrate the two left fingers and the associated average intensity vs. time curve of the two left fingers.
  • Figs. 16C and 16D illustrate the two right fingers and the associated average intensity vs. time curve of the two right fingers.
  • Figs. 16E through 16H are graphs illustrating frequency domain analyses of the average intensity vs. time curves for both the left (E and F) and right (G and H) fingers.
  • Fig. 17A is an image illustrating LSI-analyzed velocity map of perfusion to two fingers of left hand and two fingers of right hand.
  • Fig. I7B is a graph illustrating average intensity vs. time curve of .12 seconds (60 fps) image sequence of two fingers of left hand and two fingers of right hand (aggregate from all four fingers).
  • Fig. 17C is a graph illustrating standard EKG and peripheral oxygen saturation pulsatility data acquired simultaneous With the image sequence in accordance with embodiments of the present inventive concept.
  • Figs. 1 SA and 18B illustrate the two left fingers and the associated average intensity vs. time curve of the two left fingers.
  • Figs. 18C and 18D illustrate the two right fingers and the associated average intensity vs. time curve of the two right fingers.
  • Figs.18E through 18H are graphs illustrating frequency domain analyses of the average intensity vs. time curves for both the left (E and F) and right (G and H) fingers.
  • Fig, 19 is a block diagram of a data processing system according to embodiments of the present inventive coiicept(s).
  • FIG. 20 is a more detailed block diagram of the data processing system illustrated in Fig. 19 in accordance with some embodiments of the present inventive concept(s).
  • FIGs. 21 through 23 are flowcharts illustrating operations for combining images in accordance with various embodiments of the present inventive concepts).
  • FIGs. 24 A through 24D illustrate laser speckle imaging of a pig intestine in accordance with some embodiments of the present inventive concept.
  • Figs. 25 A and 25B are graphs illustrating time-domain (or spectral) analysis of MetaKG signals in accordance with some embodiments of the present inventive concept.
  • Figs. 26 A and 26B are graphs illustrating frequency-domain (or spectral) analysis of
  • Figs. 27 A and 27B are graphs illustrating Frequency-time domain (or spectrogram) analysis of MetaKG signals in accordance with some embodiments of the present inventive concept.
  • Figs. 28A and 28B are graphs illustrating residual MetaKG versus tinie/frequency in accordance with some embodiments of the present inventive concept.
  • Fig. 29 is a graph illustrating frequency-time domain (or spectrogram) analysis of residual-MetaKG signals in accordance with some embodiments of the present inventive concept.
  • Fig. 30 is a flow chart illustrating operations according to some embodiments of the present inventive concept.
  • Figs. 31 A through 31 G are images and graphs illustrating various physiologic status parameters that may be determined from a MetaKG in accordance with some embodiments of the present inventive concept.
  • Fig. 32 Is a block diagram illustrating a field of view having a sample on a background having a different set of optical characteristics in accordance with some embodiments of the present inventive concept.
  • Fig. 33 is a graph of frames versus mean iKG illustrating noise in the visible MetaKG in a palm caused by movement in the background in accordance with some embodiments of the present inventive concept.
  • Fig. 34 is a flowchart illustrating methods using a single wavelength in accordance with : some embodiments of the present inventive concept
  • Fig. 35 is a flowchart illustrating methods using multiple wavelengths in accordance with some embodiments of the present inventive concept.
  • blood flow * and “perfusion” will be used to discuss aspects of the present inven tive concept are used instead of the more technically oriented term “fluid velocity.” However, it will be understood that these terms may be used interchangeably,
  • an image refers to data that describes another form of data.
  • an image may include metadata that describes how large the picture is, the color depth, the image resolution, when the image was created, and other data.
  • a text document's metadata may contain information about how long the document is, who the author is, when the document was written, and a short summary of the document.
  • Embodiments of the present inventive concept are directed to abstracting a surrogate "metaKG” signal from any blood velocity imaging technology and analysis of that imaging tec hnology product, by calculating an average intensity vs. time curve within a region of interest (ROD as will be discussed further herein.
  • ROI region of interest
  • Embodiments of the present inventive concept may be applied to imaging technology, using one or more appropriate wavelengths to collect digital image data for use in a medical experimental or clinical context.
  • the imaging may be used for simple visualization or for more complex qualitative physiologic evaluation or even more complex quantitative physiologic evaluation without departing: from the scope of the present inventive concept.
  • CT computerized tomography
  • MRI magnetic resonance imaging
  • EKG external electrocardiogram
  • Embodiments of the present inventive concept provide methods for generating reliable instantaneous blood flow and perfusion distribution atany time of a cardiac cycle and average blood flow and perfusion distribution of several cardiac phases or cycles. Furthermore, embodiments of the present inventive concept may allow a valid comparison of blood flow and perfusion distribution in different cardiac phases and in a pre- amipost-treatment fashion,
  • a “surrogate EKG signal” (interchangeably referred to hereinafter as a “metaKG” signal or a ’’MetaKG” signal) can be calculated from the metadata contained within the image/image sequence. For example, from the average intensity' vs. time curve of a specific ROI on the image sequence, using frequency component analysis, a “metaKG” signal can be calculated and may yield the same heart rate/puisatility as an external EKG signal.
  • the “metaKG” signal may also reflect dynamic physiology; for example, when the blood vessel is occluded, the frequency component changes compared with the frequency component of the non-oeeluded control state.
  • each pixel as a field of view (FOV)
  • 2D two dimensional
  • the “metaKG” signal calculated in accordance with embodiments of the present inventive concept is not limi ted to cardiac tissue. It may be calculated and used in all tissue/organ systems where blood flow and perfusion can be imaged and measured, including skin.
  • the metaKG signal in accordance with embodiments of the present inventive concept is a multi-channel physiological signal that can be derived from the NIR image data sequence.
  • the number of channels can be up to the pixel number of die NIR image.
  • this physiological signal can not only be used as a surrogate EKG signal, but also contains other information about the physiological condition of the monitored tissue/organ,
  • average intensity within a region of interest (ROI)/multiple ROIs on the NIR image data sequence may be calculated at each time point.
  • the average intensity vs. time curve at each ROI/mulh ROIs is analyzed in time, frequency and time-frequency domain to monitor the physiological condition ofa tissue/organ,
  • embodiments of the present inventive concept provide a completely noncontact, non -mvasive tissue/organ physiological condition monitoring technology that can be used in real time.
  • the monitoring region and number of channels are much less limited than traditional monitoring technology, such as EKG.
  • This technology captures and analyzes much more information than the current products that count heart beat and pulsatility using visible li ght as will be discussed further herein with respect to Figs. I through .31.
  • non-invasive refers to -a system or method that does not require the subject to be injected with a dye, penetrated with an object or touched with an intrabody -probe or probes.
  • non-invasive refers to a sy stem or method that makes no direct contact with the subject.
  • ’’subject refers: to the person or thing being imaged,
  • the subject can be any subject including a veterinary , cadaver study or human subject
  • perfusion refers to blood flow at the tissue perfusion distribution level detected with speckle imaging.
  • the system 100 includes at least one light source 120, a camera 130, an image processing device 110 and a metaKG device 112.
  • the system of Fig. 1 is depicted as only including these elements, it will be understood that other elements may also be present in the system without departing from the scope of the present inventive concept.
  • multiple light sources 120 may be used.
  • the first light source may be a NIR light source and the second light source may be a visible light (VL) light source.
  • VL visible light
  • the NIR. light source may have a wavelength of from about 780mn to about 2500nm and the visible light source has a wavelength of from about 400nm to about 78-Onm,
  • some embodiments of the present inventive concept provide a system that uses two wavelengths of differential transmittance through a sample to apply LSI and/or EDI.
  • a first of the two wavelengths may be within the visible range that has zero or very shallow penetration, such as blue light 450-495 nm. This wavelength captures the anatomical structure: of tissue/organ surface -and serves as a position marker of the sample but not tire subsurface movement of blood flow and perfusion.
  • a second wavelength may be iit the near Infra-Red (NIR) range, which has much .deeper penetration.
  • NIR near Infra-Red
  • This wavelength reveals the: underlying blood flow physiology and correlates both to the motion of the sample and also the movement of blood flow and perfusion.
  • the true motion of blood flow and perfusion can be derived from the NIR imaging measurement without being affected by the motion artifact of the target.
  • the anatomical structure information captured by visible light and the physiological characteristics measured by NIR light are combined. Details with respect to systems using two wavelengths are discussed in detail in U.S. Provisional Application No. 62/136,010, filed March 20, 2015, the disclosure of which was incorporated herein by reference above.
  • the at least one light source unit 120 may be, for example, one or more lasers or light emitting diode (LED) lights.
  • the at least one light source 120 may be used to illuminate a region of interest 140 (hereinafter “tissue/organ”). If the light source 120 is -an NIR light source, it may have a wavelength of from about 780nm to about 2500 nm.
  • tissue/organ a region of interest 140
  • the "region of interest” refers to the regio n o f the subj ect that is being imaged, for example, the principal vessels and tissue, organs, etc.
  • a living target region of interest 140
  • part of the light will go through multiple scattering insi de the target and eventually reflect back (Reflecting light) to the camera 130 as shown in Fig. 1.
  • the camera 130 is configured to collect the reflecting light and provide a visible light or NIR image (NIR Layer 115), each with different characteristics depending, for example, upon a depth of penetration of the illumination light determined by the wavelength energy.
  • NIR near-infrared
  • Details with respect to the NIR technology is discussed m commonly assigned International Application No. PCT/US20157055251, entitled Methods, Systems and Computer Program Products for Visualizing Anatomical Structures, Blood Flowand Perfusion Using Near-Infrared Imaging (Attorney Docket No. 5218-228WO), filed on October 13, 2015, the contents of which aye hereby incorporated herein by reference as if set forth in its entirety.
  • MetaKG device 112 Contained within this image sequence or sequences 115 is metadata 118 associated with each image sequence or sequences.
  • the metaKG device 112 processes the metadata 118 associated with the image sequences and provides a "‘metaKG signal” 117, which directly links to underlying fundamen tai physiologic and/or pathophysiologic processes 121 being imaged.
  • the metaKG signals can optimize the image acquisition and may be integral to optimizing analysis of blood flow and perfusion 131.
  • a sample 140 for example, tissue or organ, with blood flow and perfusion may be examined for measurement and quantification of blood flow and perfusion 131 using non-invasive imaging, with ho need for an EKG,
  • the region of interest 140 is illuminated with two different light sources, for example, NIR and VL, and two sets of images are acquired and processed to obtain two different types of metadata, for example, NIR-metadata and VL-metadata.
  • NIR-metadata for example, NIR-metadata and VL-metadata.
  • the calculations discussed herein with respect to metadata related to a single wavelength may be performed for multiple wavelength data.
  • the NIR MetaKG -and the VL MetaKG may be calculated from the metadata
  • a movement-related common signal component may be extracted from the NIR MetaKG and the VL MetaKG
  • a noise-free MetaKG may be calculated by cancelling out the movement-related common signalcomponent from the NIR MetaKG as will be discussed further below with respect to a. single wavelength.
  • using two wavelengths in accordance with some embodiments discussed herein may improve the signal to noise ratio (SNR) of the image by combining the penetrating capability of the NIR wavelengths and the advantages of the VL wavelengths, i.e, thesuperficial surface noise of the VL may be cancelled out.
  • SNR signal to noise ratio
  • FIG. 2A illustrates the 20 seconds metaKG using near infra-red wavelength illumination
  • Fig. 2B Illustrates the 20 seconds metaKG using near visible wavelength illumination
  • Fig. 2C illustrates the 20 seconds EKG signals.
  • the metaKG is fluctuating at heart rate frequency (90 peaks per minute) and also at respiration frequency (one larger peak every 4 ⁇ 5 seconds).
  • Figs. 2 A through 2C also illustrate that the metaKG generated by near infra-red illumination has less noise than the one generated by visible wavelength illumination.
  • FIG. 3 A illustrates the 20 seconds metaKG without respiration contamination using near infra-red wavelength illumination
  • Fig. 3B illustrates the 20 seconds metaKG without respiration contamination using near visible wavelength illumination
  • Fig. 3C illustrates the 20 seconds EKG signals.
  • the metaKG is only Hue mating at heart rate frequency (90 peaks per minute).
  • the metaKG generated by near infra-red illumination has less noise than the: one generated by visible wavelength illumination.
  • Figs. 4 A through 4C are images illustrating a single frame in the raw image data sequence (4A); inversed -spatial contrast image (4B) and an inversed temporal contrast Image (4C).
  • the graph of Fig. 5 illustrates average intensity vs. time during the image acquisition period of time as the metaKG signal (end-diastolic phase in a specific cardiac cycle is labeled).
  • Figs. 4 A through 4C and 5 illustrate instantaneous blood velocity distribution of anterior wall of a heart using Laser Speckle Imaging (LSI) at the end-diastolic phase of the cardiac cycle (determined visually).
  • LSI Laser Speckle Imaging
  • Figs. 6A through 6C illustrate a single frame in the raw image data sequence (6A); an inversed spatial contrast image ,(6B); and an inversed temporal contrast image (6C).
  • Fig. 7 illustrates an average intensity vs. time curve during the image acquisition period of time as the metaKG signal (end-diastolic phase in nine (9) cardiac cycles are used).
  • Figs. 6A through 6C and 7 illustrate average blood velocity distribution of anterior wall of a heart using Laser Speckle Imaging at the end-diastolic phase of the cardiac cycle.
  • Figs. 8A through SC illustrate a single frame in the raw image data sequence (SA); an inversed spatial contrast image (SB); and an inversed temporal contrast image (SC).
  • Fig. 8D illustrates an average intensity vs. time- curve during the image acquisition period of time as the metaKG signal (end-systolic phases in eight (8) cardiac cycles are used).
  • Figs. SA through 8D illustrate average blood velocity distribution of anterior wall of a heart using Laser Speckle Imaging at the end-systolic phase of the cardiac cycle (determined visually).
  • Figs. 9A through 9B illustrate using an average intensity vs. time curve as the metaKG signal in a potential Cardiac application to assess blood flow and perfusion.
  • Fig. 9C illustrates the average intensity vs. time curve as the metaKG signal -with diastolic and systolic phases labeled.
  • Fig. 9A illustrates one frame of raw -image data sequence in diastolic phase and
  • Fig. 9B illustrates one frame of raw image data sequence in systolic phase
  • FIGs. 10A through 10C using average intensity vs. time curve as the metaKG signal in a potential skim'peripherai extremity application to assess blood flow and perfusion will be discussed.
  • Figs. I0A and 1 OB illustrate a finger perfusion measurement setup.
  • Fig. 10A illustrates one frame from raw image data sequence, with flow to the two left fingers reduced by greater than 70% by inflation of a blood pressure cuff on the left arm.
  • Fig. I0B illustrates the blood Velocity distribution, illustrating this substantial reduction in flow’ and perfusion to the left fingers.
  • Fig. 10C is a graph illustrating an average intensity vs. time curve as the metaKG signal.
  • FIGs. 11 A through 18H use of the average intensity vs. lime curves as the metaKG signal in a different finger perfusion measurement experiment will be discussed.
  • These figures illustrate a potential skin/peripheral extremity application to assess blood flow and perfusion.
  • the figures document the interoperability of the metaKG, the external standard EKG, flow, velocity of flow, frequency, and change in frequency due to pathophysiologic changes in flow and perfusion in accordance with embodiments discussed herein.
  • FIG. 11 B illustrates the average intensity vs. time curve of 12 seconds (60 ips) image sequence of two fingers of left hand and two fingers of right hand (aggregate from all four fingers).
  • Fig. 11 A illustrates an LSI-analyzed velocity map of perfusion to all four fingers.
  • Fig. 11.C illustrates standard EKG and peripheral oxygen saturation pulsatility data, acquired simultaneous with the image sequence. The metaKG Irate” is 73 beats/mln (bpm), while the recorded standard EKG rate is 74 bpm.
  • FIGs. 12A through 12H using the same data as in Figs. 11 A-C, this baseline data is further analyzed.
  • Figs. 12B and 12D illustrate the wave form of the average intensity vs. time curve of the two left (12A) and two right (12C) finger sets, respectively, and show that they are similar (L - 73 bpm, R ⁇ 74 bpm).
  • Figs. 12E/F and I.2G/H are frequencydomain analyses of the average intensity vs. time curves, which document that the main frequency component in both finger sets is the heart rate (HR), and that the main frequency component of the two left fingers (Figs. 12E and 12F) and two right fingers (Figs.
  • HR heart rate
  • FIG. 12G and 12H are virtually identical.
  • Figs. I3A through 13 C results of the same experimental setup as Figs. 11A-12H, but now flow and perfusion to the left two fingers (Fig. 13A) are occluded by the blood -pressure cuff will be discussed.
  • the peripheral oxygen saturation measurement is made from the third digit on the left hand.
  • Fig. 13B illustrates an average intensity vs. time curve of 12 seconds (60 fps) image sequence of two fingers of left hand and two fingers of right hand (Fig. ISA).
  • Fig. 13C illustrates the standard external EKG .and peripheral oxygen saturation pulsatility data acquired simultaneous with the image sequence. With the finger occlusion, the metaKG signal (aggregate from all four fingers) differs slightly from the .standard EKG (72 bpm ys. 69 bpm).
  • FIGs. 14A through 14H analysis is similar to that discussed above with respect to Figs. 12A-H.
  • the flow .and -perfusion to .the left finger set (14A) are occluded, while the right finger set (14C) is normally perfused as the control.
  • Figs. 14B and 14D illustrates the wa ve form of the average intensity vs. time curve as the metaKG of the left (14B) and right finger sets (14D), and that they are different.
  • Figs. 14E/F and 14G/H illustrate the frequency domain analy sis of the average intensity' vs. time curves.
  • FIG. 14G/H illustrate the main frequency component of the non-occluded right finger set (14D) is sti ll the HR
  • Figs. 14EZF illustrate the frequency component of the occluded left finger set is degraded from the perfused condition in Figs. 12E/F, and very different from the frequency component of the two right fingers (Figs. G/H).
  • Figs. 14A through 14H illustrate that there is a difference in the metadata (B&D) because blood flows to the fingers in A are occluded and those in C are not.
  • the strength of intensity fluctuation in D and G are much greater than that in B and E. In other words, when the blood flow is blocked, the metadata (MetaKG) may weaken.
  • FIG. 15A through 15C results of the same experimental setup as prior figures, but now the blood cuff on the left arm has been released and both, finger sets are perfused again (note the time stamp from the standard EKG display) will be discussed.
  • Fig. 15B illustrates the average intensity vs. time metaKG curve of 12 seconds (60 fps) image sequence of two fingers of left hand and two fingers of right hand (Fig. i 5 A).
  • Fig. 15C illustrates bottom panel is the standard external EKG and peripheral oxygen saturation pulsatility data acquired simultaneously with, the image, sequence. The metaKG rate is 72 bpm versus the standard EKG rate of 75 bpm.
  • FIG. 16A through 16H an analysis is similar to Figs, 12 and 14 above will be discussed.
  • Figs. 16B and 16D illustrate the wave form of the average intensity vs.time curve of the left (16A) and right (16C) finger sets are similar after the occlusion on the two left fingers (I6A) are released.
  • Figs. 16E/F and 16G/H illustrate the frequency domain analyses of the average intensity ys, time curves, which again illustrate that the main frequency component is the HR, and that the main frequency component of the left finger set (16E/F) and the right finger set (16G/H) are identical again after the occlusion to the left finger set is released, [00111] Referring now to Figs. 17A through 17C, using the same experimental setup as Fig.
  • Fig. 17B is the average intensity vs. time curve of 12 seconds (60 fps) image sequence of the left and right finger sets (17A)
  • Fig. 17C illustrates the standard external EKG and peripheral oxygen saturation pulsatility data acquired simultaneously with the image sequence.
  • Figs. 18B and 18D illustrate that wave forms of the average intensity vs. time curve of the left (I SA) and right (18C) finger sets are similar.
  • Figs. 18E/F and 18G/H illustrate that the frequency domain analyses of the metaKG data, which show the main frequency component is the HR in both finger sets (18 A and 18C), and that the main frequency component of the two left fingers (Figs. 18E/F) and two right fingers (Figs, 18G/H) are identical.
  • the blood flow and perfusion are dynamic processes that change in one cardiac cycle, it is critical to synchronize the imaging measurement results with a reference signal.
  • the reference signal is the externalelectrocardiogram ( EKG) signal.
  • EKG externalelectrocardiogram
  • the precision of a benchmark like the EKG is useful for defining the starting and ending points of the averaging process, versus simply finding a random starting point and averaging a few seconds of flow and perfusion measurements, where quantitative comparison of the average flow and perfusion maps is indicated.
  • Embodiments of the present inventive concept address situations where an EKG signal is not available or desirable.
  • embodiments of the present inventi ve concept provide -a “surrogate EKG signal” that can be used instead of th ⁇ standard EKG signal to identify and target these physiologic processes, benchmarks, data acquisition and data analysis parameters.
  • the “surrogate EKG signal’’ has been referred to herein as a “MetaKG signal.”
  • the MetaKG in accordance with embodiments di scussed herein consists of an electrical, mechanical, and/or motion signal embedded in the metadataof the image file(s) obtained by imaging across or within the visible and near-infrared spectrum wavelengths.
  • the surrogate EGK signal is referred to herein as “metaKG.”
  • the metaKG is imbedded in the average intensity vs. time curve of the raw image data sequence.
  • an average intensity is calculated at each frame to form a curve of 1000 intensity points along the 0-10 second time line. Due to contraction of the heart, the imaged tissue/organ will move toward and away from the camera causing the intensity to fluctuate periodically. The fluctuation of intensity shows a certain pattern in one cardiac cycle and repeats itself different cardiac cycles.
  • Figs. 10A through 10C illustrate a metaKG signal in accordance with embodiments discussed herein from finger digits of the upper extremities, despite being located quite far from the heart .
  • the metaKG signal yields the same heart rate as the real EKG signal and peripheral oxygen saturation pulsatility data (73 bpm vs. 74 bpm).
  • the frequency component of the average intensity vs. time curve metaKG from the occluded tissue changes compared with the frequency component from the non-occluded control tissue metaKG, as illustrated in Figs.13A- C.
  • the main frequency component of the metaKG average intensity vs. time curve from the non-occluded control tissue is still the HR which is consistent with the external EKG reading while the frequency component of average intensity vs. time curve from the occluded tissue becomes more complex. This indicates the presence of a different and abnormal underlying physiological response.
  • Figs. 17 A through 17C and ISA tlrrough 18H demonstrate that when the heart rate is elevated (HR 103 bpm), the frequency components of the average intensity vs. time metaKG curves from different normal tissues are similar. This indicates that metaKG signal HR is the main frequency component, which again i s consistent with the external EKG tracing obtained at the same time. [0(1125] Accordingly, as discussed briefly above, using an EKG signal to track time during the image acquisition is useful to link each specific bipod flow and perfusion distribution to its cardiac phase.
  • this method can generate reliable instantaneous blood flow and perfusion distribution at any time ofa cardiac -cycle and average blood flow and perfusion distribution of several cardiac phases or cycles. Furthermore, this method allows the valid comparison of blood flow and perfusion distribution in different cardiac phases and in a pre and post treatment fashion.
  • the link between EKG and image acquisition and subsequent instantaneous- and average blood flow and perfusion measurement upgrades any current blood flow and perfusion imaging technology into a more practical, reliable, precise and clinically relevant methodology .
  • a metaKG signal can be calculated from the average intensity vs. time curve of a specific region of interest on the image sequence.
  • the metaKG signal yields reliable heart rate/pulsatility information using frequency component analysis.
  • the frequency component changes compared with the frequency component of the non-occluded control tissue indicating underlying physiological response.
  • a data processing system 200 that may be used in the system 100 illustrated in Fig. I in accordance with some embodiments of the in venti ve concept will be discussed .
  • the data processing sy stem 200 may be included in the metaKG device 112, the camera 130 or split between various elements of the system 100 without departing from the scope of the present inventi ve concept.
  • an exemplar/ embodiment of a data processing system 200 suitable for use in the system 100 of Fig. I includes a user interface 244 such as a keyboard, keypad, touchpad or the like.
  • the I/O data ports 246 can be used to.transfer information between the data processing system 200 and another computer system or a network.
  • These components may be conventional components, such as those used in many conventional data processing systems, which may be configured to operate as described herein.
  • the processor 238 communicates with, a display 345 via and address/’data bus 347, the memory 236 via an address/data bus 348 and the I/O data ports 246 via an address/date bus 349.
  • the processor 238 can be any commercially available or custom microprocessor or ASICs.
  • the memory' 236 is representative of the overall hierarchy of memory devices containing the software and data used to implement the functionality of the data processing system 200.
  • the memory 236 can include, but is not: limited to, the following types of devices-, cache, ROM, PROM, EPROM. EEPROM, flash memory, SRAM, and DRAM.
  • the memoiy 236 may include several categories of software and data used in the data processing system 200: an operating system 352; application programs 354; input/output (I/O) device drivers 358; and data 356.
  • the operating system 352 may be any operating system suitable for use with a data processing system, such as Mac OSX, OS/2, AIX or zOS from International Business Machines Corporation, Armonk, NY, Wmdows95, Windowses, Windows2000, WindowsXP, Windows 8, Windows 10 or Vista from Microsoft Corporation, Redmond, WA, Unix, Linux, LabView, or a real-time operating system such as QNX or VxWorks, or the: like.
  • the I/O device drivers 358 typically include software routines accessed through the operating system 352 by the application programs 354 to communicate with devices such as the I/O data port(s) 246 and certain memory 236 components.
  • the application programs 354 are illustrative of the programs that implement the various features of the data processing system 200 included a system in accordance with some embodiments of the present inventive concept and preferably include at least one application that supports operations according to some embodiments of the present inventiveconcept
  • the data 356 represents the static and dynamic data used by the application programs 354, the. operating system 352, the I/O device drivers 358, and other software programs that may reside in the memory 236.
  • the data 356 may include acquired images 360, image metadata 361, physiologic signal data 363, calculated blood flow/perfiision rates (velocity data) 364 and MetaKG data 365.
  • the data 356 illustrated in Fig. 20 includes five different files 360, 36 L 363, 364 and 365 embodiments of the present inventive concept are not limited to this configuration. Two or more files may be combined to make a single file: a single file may be split into two or more files and the like without departing from the scope of the present inventive concept
  • the application programs 354 may include a metadata module 351, an image capture module 352, a MetaKG module 353 and velocity module 354 in accordance with some embodiments ofthe inventive concept. While the present inventive concept is illustrated, for example, with reference to the metadata module 351 , the image capture module 352, the MetaKG module 353 and the velocity module 354 being application programs in Fig. 20, as will be appreciated by those of skill in the art, other configurations may also be utilized while still benefiting from the teachings of the present. Inventive concept.
  • the metadata module 351, the image capture module 352, the MetaKG module 353 and the velocity module 354 may also be incorporated into the operating system 352 or other such logical division of the data processing system 300.
  • the present inventive concept should not be construed as limited to the configuration of Fig. 20, but is intended to encompass any configuration capable of carrying out the operations described herein.
  • MetaKG module 353 and the velocity module 354 are illustrated in a single data processing sy stem, as will be appreciated by those of skill in the art, such functionality may be distributed across one or more data processing systems.
  • the present inventive concept should not be construed as limited to the- configuration illustrated in Figs. 19 and 20, but may be provided by other arrangements andtor divisions of function between data processing systems.
  • At least one source 120 may illuminate a sample of tissue/organ and light may be reflected into a camera.
  • the camera 130/image capture module 352 may receive the reflected light and provide it to the imaging processing device 110 to provide an image 360,
  • These images may be processed (metadata module 351) to provide metadata 361 associated therewith and -an MetaKG signal 365 (surrogate EKG signal) may be determined by the MetaKG module 353 using the Physiologic signal data 363 and the metadata 361 as discussed above.
  • this surrogate EKG signal (MetaKG signal) may be used to provide blood flow and perfusion data 364 by the velocity module 354.
  • the data 356 may be used by the metaKG module 353 to provide blood flow and perfosion data synchronized with a surrogate EKG signal (metaKG signal).
  • Operations for calculating a MetaKG signal begin at block 2115 by illuminating a region of interest in a sample with at least one light source, for example, a near-infrared (NIR) light source and/or a visible light source. Images of the region of interest are acquired (2125). The acquired images are processed to obtain metadata associated with the acquired images (block 2135). The MetaKG signal is calculated from, the metadata associated with the acquired images (block 2145), In some embodiments, the MetaKG signal may be calculated or derived from one of raw (reflectance images) images and perfusion (analyzed) images (processed images). In some embodiments, the sample may be one of tissue and an organ.
  • NIR near-infrared
  • blood flow and perfusion data may be acquired using the calculated MetaKG signal (block 2155). Dotted lines indicating optional subject matter.
  • At least one of heart rate and pulsatility information may be .calculated from the average intensify versus time in the region of interest by analyzing a frequency component of the average intensity versus time (block 2227).
  • HRV heart rate variability
  • HRV heart rate variability
  • the term, “heart rate variability” refers to a measure of changes of the heart rate over time. This change may be large or small, and over a small or large time-interval. Normally, the heart rate is not absolutely regular, and one can quantify the degree of changes of the heart rate over a certain period of time, fbr example, the heart beats faster and slower with respiration.
  • HRV Some types of HRV are indicative, of abnormal physiological status, and/or diseases.
  • Abnormal and normal tissue may be differentiated based on a frequency component of tire average intensity versus time (block 2237).
  • a degree of abnormality related to an underlying physiological response may be indicated (block 2247).
  • a configuration of the region of interest may be changed (block 2318), For example, one of the size and the location of the region of interest may be changed, A two dimensional heart rate map may be generated of a region of interest in a field of view (block 2328).
  • a surrogate EKG may be calculated using average intensity of the raw images.
  • the MetaKG may be calculated using average intensity of speckle contrast images as will be discussed further below with respect to Figs. 24A through 29.
  • Embodiments of the present inventive concept illustrated in Figs. 24A through 29 discuss processing the images in the time domain, frequency domain and the time- frequency .domain- as discussed below.
  • Figs. 24A through 29 discuss processing the images in the time domain, frequency domain and the time- frequency .domain- as discussed below.
  • 2A - 3B, .5, 7, 8D, 9C, 100, 1 IB, 12B, 12D, 13B, I4B, 14D, 15B, 16B, 16D, 17B, 188 and 18D illustrate MetaKG signals calculated from a raw image(reflectance image) in accordance with some embodiments of the present inventive concept.
  • Figs. 24A and 24B illustrate a raw NIR laser speckle image and a NIR laser speckle contrast image, respectively.
  • Figs. 24C and 24D illustrate a raw VL laser speckle image and a VL laser speckle contrast image, respectively.
  • the difference between the raw laser speckle images (24A and 24C) and the laser speckle contrast images (24B and 24D) is more apparent in the NIR images (24A and 24B) than it is in the VL images (24C and 24D). This is indicative of the fact the NIR laser speckle contrast image (24B) provides better insights into blood flow and perfusion than the raw NIR laser speckle image (24A).
  • Figs. 25A and 25B graphs illustrating time-domain (or spectral) analysis of MetaKG signals will be discussed.
  • Fig, 25 A illustrates an NIR-MetaKG (X) versus time
  • Fig. 25B illustrates a VL-MetaKG ( ⁇ ) versus time.
  • the X lines on both plots represent the large amplitude slow trend of the MetaKG caused by the respiratory activity related movement.
  • Both NIR-MetaKG ( ⁇ V) and VL-MetaKG ( ⁇ ) are contaminated by this noise to the same degree.
  • Figs. 26A and 26B graphs illustrating frequency-domain (or spectral) analysis of MetaKG signals will be discussed.
  • Fig. 26A illustrates the Power Spectral Density (PSD) of NIR-MetaKG versus frequency
  • Fig. 26B illustrates the PSD of VL- MetaKG versus frequency, both graphs illustrating respiratory activity and cardiac activity in the frequency domain.
  • PSD is a measure of strength of a given signal’s specific frequency components.
  • Figs. 27A and 27B graphs illustrated frequency-time domain (or spectrogram) analysis of MetaKG signals will be discussed.
  • Fig. 27A illustrates a spectrogram of NIR-MetaKG
  • Fig. 27B illustrates a spectrogram of VL-MetaKG, both including cardiac and respiratory activity.
  • the spectrogram of MetaKG signals reveals the frequency -domainspectral contents of the signals over time. Both MetaKG signals are severely contaminated by the respiratory activity related noise.
  • the spectrogram of the NIR-MetaKG (27A) shows a slight sign of cardiac activity' (labeled line ), which is much weaker than the respiratory acti vity related noise.
  • FIG. 28A illustrates residual-MetaKG versus time
  • Fig. 28B illustrates residual- MetaKG versus: frequency .
  • the PSD of the residual-MetaKG (Fig.283) clearly shows that the signal’s dominant component is related to tile cardiac activity (about 90 bpm), not the respiratory activity.
  • Fig. 29 a graph illustrating frequency-time domain (or spectrogram) analysis of the residual-MetaKG will be discussed.
  • the spectrogram of the residual-MetaKG signal illustrates in Fig. 29 reveals that the signal is free from the respiratory activity related noise.
  • the instantaneous heart, rate changing over time is marked thereon.
  • HRV heart rate variability
  • operations for removing: movement-related artifacts from a MetaKG signal using dual wavelength light sources begins at block 3050 by illuminating a region of interest in a sample with a near-infrared (NIR) light source and a visible light (VL) source. Two sets of images of the region of interest are acquired, each corresponding to one of the NIR light source and the VL source (block 3053). The two sets of images are processed to obtain NIR-metadata and VL-metadata (block 3:055). .An NIR MetaKG and a VL MetaKG are calculated from the NIR- metadata and the VL metadata, respectively (block 3057). A movement-related common signal component is extracted from the NIR MetaKG and the VL MetaKG (block 3058). A noise-free MetaKG is calculated by cancelling out the movement-related common signal component from the NIR MetaKG (block 3059).
  • NIR near-infrared
  • VL visible light
  • embodiments of the present inventive concept that use multiple wavelengths to acquire multi- spectral images can remove noise due to motion artifacts caused by, for example, respiratory activity (Figs.26-29).
  • Single wavelength technologies may not be able to effectively remove such noise artifacts.
  • HSP Hemodynamic Status Parameters
  • the HSPs may include Heart Rate (HR), heart rate variability (HRV), R-to-R interval (RR1), and RRI Standard Deviation (RRISD) as illustrated in Fig. 31C, systolic Blood Pressure threshold (SBt) as illustrated in Fig.
  • HR Heart Rate
  • HRV heart rate variability
  • RR1 R-to-R interval
  • RRISD RRI Standard Deviation
  • SBt systolic Blood Pressure threshold
  • the MetaKG may be used to derive additional HSPs such as tissue oxygen content, hemoglobin content, temperature, and the like.
  • additional HSPs such as tissue oxygen content, hemoglobin content, temperature, and the like.
  • embodiments of the present inventive concept may be used in any format of clinical imaging, which includes both surgical imaging (usually an in-patient application) and other out-patient imaging procedure (non-surgical application) without departing from the scope of the present inventive concept
  • Figs. 32 through 35 methods for providing improved images of samples using embodiments of the present inventive.-concept discussed above with respect to Figs. 1 through 31 G will be discussed.
  • Using embodiments of the present inventive concept to calculate an accurate MetaKG signal for a region of interest it has been determined that when ah portions of the region of interest have a same or similar set of optical characteristics, for example, when the region of interest is an internal organ, the “background’' behind the organ or region of interest does not generally interfere significantly with the image and/or the resulting MetaKG signal.
  • the region of interest is provided on a background that has a different set of optical characteristics than the region of interest, for example, when a hand is imaged on a table or dark background, this background may have different optical characteristics that could alter the image and/or resulting MetaKG signal.
  • FOVs field of views
  • embodiments of the present inventive concept may be discussed herein with respect to imaging a hand on a dark; background, where the hand has blood flow and the background does not, thus, having different optical characteristics, it will be understood that embodiments of the present inventive concept are not limited to this example.
  • Embodiments of the present in ventive concept may be used in combination with any environment where the results may benefit from a correction factor due to different sets of optical characteristics. For example, during a surgical procedure towels or drapes may be positioned around the field of view to block out the areas around the tissues of interest in the field of view. Thus, the tissue in the field of view and the towels will not have the same set of optical characteristics.
  • set of optical characteristics refers to the biologic versus non- biologic nature of the materials being illuminated in the field of view.
  • the optical properties of a biological tissue are described in terms of the absorption coefficient, g.a (cjn-1), the scattering coefficient us (cm-1), the scattering phase function p(0, j) where the polar angle of scatter andj (0 ⁇ J ⁇ 2K) is the azimuthal angle of scatter, and the refractive index of the tissue, n.
  • Optical scattering can be described either as scattering by particles that have a refractive index different from the surrounding medium, or as scattering by a medium with a continuous but fluctuating refractive index.
  • These optical properties (absorption, scattering, anisotropy, reduced scattering, refractive index) vary between different biological tissues, and between different biological tissues in the same: field of view.
  • these tissue optical characteristics will be different for the same tissue depending upon the illumination source, for example visible light versus NIR, or different wavelengths within the visible spectrum or the NIR spectrum.
  • the biological optical characteristics differ from the optical characteristics of nonbiologic materials, for example, background, towels or drapes, surgical instruments, foreign bodies, or other such inert materials, which are separately defined by tire nature of the non- biologic materials themselves.
  • nonbiologic materials for example, background, towels or drapes, surgical instruments, foreign bodies, or other such inert materials, which are separately defined by tire nature of the non- biologic materials themselves.
  • laser speckle contrast of biological material such as tissue
  • laser speckle contrast of non-biologic materials such as background are differentiated through laser speckle imaging analysis.
  • Fig. 32 is a block diagram illustrating a field of view 3242 including a sample 3240 positioned on a background 3241 will be discussed.
  • the sample 3241 may be any sample to be imaged in a field of view.
  • the “background’' may be any background 3241 that has a different set of optical characteristics than the sample to be imaged.
  • all tissue in the field of view may all have the same tissue structure and, therefore, have the same or similar set of optical characteristics.
  • the set of optical characteristics of the sample m the fi eld of view effect the resulting calculatedMetaKG signal.
  • Fig. 33 is a graph illustrating frames; versus mean iKG.
  • the sample is a human palm positioned on a background.
  • the graph illustrates the NIR iKG of the background (A) and the palm (B) and the visible (VIS) iKG of the background (C) and the palm (D).
  • VIS visible iKG of the palm (I)
  • some embodiments of the present inventive concept provide a method for correcting a calculated MetaKG signal when the field of view includes a sample and a background having different sets of optical characteristics. For example, a MeiaKG signal may be calculated forthe field ofview and a second MetaKG signal may be calculated for the background and then the background MetaKG signal may be subtracted out of or removed from the MetaKG signal of the field of view as will be discussed further below.
  • a multi-spectral MetaKG signal may be calculated by calculating a residual MeiaKG wherein is raw or speckle contrast images of a first wavelength; raw or speckle contrast images of a second wavelength; a. b and c are parameters for normalization; and M and N are a number of pixels along x and y axes, respectively
  • Imgll may be NIR and ImgX2 may be visible (VIS) as illumination sources.
  • VIS visible
  • the two (or more) wavelengths cross-contaminate in the standard metaKG analysis, mostly through translational motion of the tissues causing a false positive LSCI indication of flow and perfusion.
  • Img ⁇ 1 may be NIR and Imgl2 in equations (1) and (2) with
  • ImgX3 representing the background NIR, and ImgM representing the background VIS, respectively, may provide data with respect to the “background” in the Field of View, As discussed above, this background could be an opaque flat pad on which the hand is imaged, or the towel drapes placed to isolate the tissues of interest in the operating room.
  • the characteristic of the “background” is that it is inert material with known optical properties , it should not be moving or exhibiting any translational motion, and that there should not be any BFD signal in tills inert materiaL
  • the background MetaKG-NIR and the background MetaKG-VlS thus, represent additional - “corrective” factors that, can be applied.
  • both the background signals (NIR and VIS) should be flat. However, in reality, they may not be. Any actual BFD signal obtained from the background is a false positi ve that could be used to further refine the analyses of actual BFD.
  • MetaKG signals calculated for the background (NIR and VIS) to adjust theMetaKG for thd region of interest.
  • NIR and VIS background
  • tire MetaKG can be calculated using any number of methods without departing from the scope of the present Inventiveconcept.
  • a MetaKG may be calculated using one wavelength or multiple wavelengths.
  • Fig. 34 Operations for calculating a MetaKG signal for a region of interest in asample using a single wavelength begin at block 3400 by illuminating a region of interest in a sample with a light source having a single wavelength.
  • the single wavelength in some embodiments is in the NIR range,
  • the region of interest has a sample portion 3240 (Fig. 32) having a first set of optical characteristics and a background portion (3241) having a second set of optical characteristics.
  • Images of the region of interest are acquired (block 3410).
  • the acquired images of the region of interest are processed to obtain metadata associated with the acquired Images (block 3420).
  • a MetaKG signal for the region of interest is calculated from the metadata associated with the acquired images (block 3430).
  • a background MetaKG signal is also calculated from the metadata associated with the background portion of the region of interest (block 3440).
  • the calculated MetaKG signal for the region of interest is adjusted using the calculated background MetaKG to provide a final adjusted MetaKG signal for the region of interest (block 3450).
  • the MetaKG signal can be adjusted in many ways using the background MetaKG signal. For example, the background MetaKG signal may be subtracted from the MetaKG signal for the region of interest.
  • Fig. 35 operations for calculating a MetaKG signal using multiple wavelengths begin at block 3500 by ilkmimating a region of interest in a sample with at least one multi-wavelength light source.
  • the region, of interest includes a sample portion and a background portion.
  • the multiwavelength light source may be a near-infrared (NIR) light source and/or a visible light source and in some embodiments is both.
  • NIR near-infrared
  • Multi-spectral images of t he region of interest are acquired using a multi-wavelength camera (block 3510).
  • the .acquired multi-spectral images are processed to obtain metadata associated with the acquired multi-spectral images (block 3520).
  • a background MetaKG signal is calculated for the background portio n of the region of interest from the metadata associated with the acquired multi-spectral images (block 3530).
  • a MetaKG signal is calculated for the region of interest from the metadata associated with the acquired multi-spectral images (block 3540).
  • the calculated MetaKG signal for the region of interest is adjusted using the calculated background MetaKG signal to provide a final adjusted MetaKG signal (block 3550).
  • Calculating the background MetaKG signal and the MetaKG signal for the region of interest comprises calculating a multi -spectral MetaKG signal using multi -spectral signal processing to remove motion artifacts and improve signal quality using equations (1 ) and (2) above.
  • calculating the background MetaKG signal includes first calculating a background MetaKG signal for both near-infrared (NIR) and visible wavelengths to provide a background MetaKG signal NIR and a background MetaKG signal visible.
  • the background MetaKG signal NIR may be adjusted using the background MetaKG signal visible if necessary.
  • the MetaKG signal for the region of interest may be calculated by calculating a MetaKG signal for the region of interest for visible: wavelengths to provide a MetaKG signal visible for the region of interest.
  • the calculated the MetaKG signal visible for the region of interest may be reserved for any motion artifact present therein.
  • a window of frames may be selected for NIR analysis for the region of interest.
  • a MetaKG signal for the: region of interest for NIR wavelengths may be calculated to provide a MetaKG signal NIR for the region of interest using the selected window.
  • the MetaKG signal visible for the region of interest may be normalized using the background MetaKG signal visible to orovide the final adjusted MetaKG signal for the region of interest. This process may optimize the: MetaKG NIR flow an perfusion pathway for the region of interest.
  • the visible MetaKG may be used to identify translational motion from the MetaKG- VIS as a first step. Then, a section of the MetaKG- VIS that is stable and flat, i,e. has no translational motion, may be used to identify where the RAW frames are located where the MetaKG-NIR can be analyzed, thus, translational movement may be reduces in the analysis. There also may be other possible signals in the VIS wavelength that may improve the MetaKG-NIR analyses beyond just mathematical processes.
  • the background data may be process prior to MetaKG or residual metaKG analysis.
  • the background nietaKG-VIS may be used to confirm absence.of motion artifact
  • Background metaKG-VIS and background metaKG-NIR may be compared and this comparison may be used to assess false positivity in background MetaKG- NIR. This may be used to ‘correct'’ the MetaKG-NIR or residual MetaKG-NIR.
  • the backgrotmd-NlR may be matched to background-VlS to provide an optimal window for selection for analysis.
  • the corrected background-NIR may be used to normalize the MetaKG- NIR or residual MetaKG-NIR analysis, as “true baseline of zero perfusion’’ for that imaging encounter. This approach may be used to ‘normalize’ MetaKG or residual MetaKG to a standard baseline value, within subjects and also across subjects
  • embodiments of the present inventi ve concept discussed with respect Figs. 32 through 35 utilize the concepts discussed in prior portions of the application to further refine the final MetaKG.
  • embodiments of the present inventive concept may provide more accurate results.
  • Example embodiments are described above with reference to block diagrams and/or flowchart illustrations of methods, devices, systems and/or computer program products. It isunderstood that a block of the block diagrams and/or flowchart illustrations, and combinations of blocks in the block diagrams and/or flowchart illustrations, can be implemented by computer program instructions. These computer program instructions may be provided to a processor of a general purpose computer, special purpose computer, and/or other programmable data processing apparatus to produce a machine, such that the instructions, which execute via the processor of the computer and/or other programmable data processing apparatus, create means (functionality) and/or structure for implementing the fonefions/acts specified In the block diagrams and/or flowchart: block or blocks.
  • These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including instructions which implement the fuiictions/actsspecified in the block diagrams- and/or flowchart block or blacks.
  • the computer program instructions may also be loaded onto a computer or other programmable data processing apparatus: to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer-implemented process such that the instructions which execute on the computer or other programmable apparatus provide steps for implementing the functions/acts specified in the block diagrams and/or flowchart block or blocks.
  • example embodiments may be implemented in hardware and/or in software (including firmware, resident software, micro-code. etc.). Furthermore, example embodiments may take the form of a computer program producton a computer-usable or computer-readable storage medium having computer-usable or computer-readable program code embodied in the medium for use by or in connection with an instruction execution system.
  • a computer-usable or computer-readable medium may be any medium that can contain, store, communicate, propagate, -or transport the program for use by or in connection with the instruction execution system, apparatus, or device.
  • the computer-usable or computer-readable medium may be, for example but not limited to, an electronic, magnetic, optical, electromagnetic, infrared, or semiconductor system, apparatus, device, or propagation medium. More specific examples (a non-exhaustive list) o f thecomputer-readable medium would include the following: an electrical connection having one or more wires, a portable computer diskette, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or Flash memory), an optical fiber, and a portable compact disc read-only memory (CD-ROM).
  • RAM random access memory
  • ROM read-only memory
  • EPROM or Flash memory erasable programmable read-only memory
  • CD-ROM portable compact disc read-only memory
  • the computer-usable or computer-readable medium could even be paper or another suitable medium upon which the program is printed, as the program can be electronically captured, via, for instance, optical scanning of the paper or other medium, then compiled, interpreted, or otherwise processed in a suitable manner, ifnecessary, and then stored in a computer memory.
  • Computer program code for carrying out operations of data processing systems discussed herein may be written in a high-level programming language, such as Java, AJAX (Asynchronous JavaScript), C, and/or C+fo for development convenience.
  • computer program code for cany ing out operations of example embodiments may also be written in other programming languages, such as, but not limited to, interpreted languages.
  • Some modules or routines may be .written in assembly language or even micro-code to enhance performance and/or memory usage.
  • embodiments are not limited to a particular programming language.
  • any or all of the program modules may also be implemented using discrete hardware components, one or more application specific integrated circuits (ASICs), or a field programmable gate array (FPGA), or a programmed digital signal processor, a programmed logic controller (PLC), or microcontroller.
  • ASICs application specific integrated circuits
  • FPGA field programmable gate array
  • PLC programmed logic controller
  • the functions/acts noted in the blocks may occur out of the order noted in the flowcharts. For example, two blocks shown in succession may in fact be executed substantially concurrently or the blocks may sometimes be executed in thereverse order, depending upon the functionality/acts involved.
  • the functionality of a given block of the flowcharts and/or block diagrams may be separated into multiple blocks and/or the functionality of two or more blocks of the flowcharts and/or block diagrams may be at least partially integrated.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Signal Processing (AREA)
  • Data Mining & Analysis (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Databases & Information Systems (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Image Processing (AREA)

Abstract

La présente invention concerne des procédés de calcul d'un signal Méta KG. Le procédé comprend l'éclairage d'une région d'intérêt (2115) dans un échantillon avec une source de lumière proche infrarouge (NiR) et/ou une source de lumière visible. La région d'intérêt comprend une partie échantillon et une partie arrière-plan, ayant chacune un ensemble différent de caractéristiques optiques. Des images de la région d'intérêt sont acquises (2125) et traitées pour obtenir des métadonnées (2135) associées aux images acquises. Des signaux Méta KG sont calculés (2145) pour la région d'intérêt et pour l'arrière-plan. Le signal Méta KG pour l'arrière-plan est utilisé pour ajuster le signal Méta KG pour la région d'intérêt pour fournir un signal Méta KG ajusté final pour la région d'intérêt.
PCT/US2021/049608 2020-10-05 2021-09-09 Procédés, systèmes et produits-programmes informatiques pour calculer des signaux métakg pour des régions ayant de multiples ensembles de caractéristiques optiques WO2022076122A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3196709A CA3196709A1 (fr) 2020-10-05 2021-09-09 Procedes, systemes et produits-programmes informatiques pour calculer des signaux metakg pour des regions ayant de multiples ensembles de caracteristiques optiques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17/062,989 2020-10-05
US17/062,989 US11553844B2 (en) 2014-10-14 2020-10-05 Methods, systems and computer program products for calculating MetaKG signals for regions having multiple sets of optical characteristics

Publications (1)

Publication Number Publication Date
WO2022076122A1 true WO2022076122A1 (fr) 2022-04-14

Family

ID=78087530

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/049608 WO2022076122A1 (fr) 2020-10-05 2021-09-09 Procédés, systèmes et produits-programmes informatiques pour calculer des signaux métakg pour des régions ayant de multiples ensembles de caractéristiques optiques

Country Status (2)

Country Link
CA (1) CA3196709A1 (fr)
WO (1) WO2022076122A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016061041A1 (fr) * 2014-10-14 2016-04-21 East Carolina University Procédés, systèmes et produits de programme informatique pour déterminer des paramètres d'état hémodynamique au moyen de signaux dérivés d'imagerie multispectrale de circulation et perfusion sanguine
US20160270672A1 (en) * 2015-03-20 2016-09-22 East Carolina University Multi-Spectral Laser Imaging (MSLI) Methods and Systems for Blood Flow and Perfusion Imaging and Quantification
US20170017858A1 (en) * 2015-07-15 2017-01-19 Samsung Electronics Co., Ltd. Laser speckle contrast imaging system, laser speckle contrast imaging method, and apparatus including the laser speckle contrast imaging system
WO2020045015A1 (fr) * 2018-08-28 2020-03-05 ソニー株式会社 Système médical, dispositif de traitement d'informations et méthode de traitement d'informations

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016061041A1 (fr) * 2014-10-14 2016-04-21 East Carolina University Procédés, systèmes et produits de programme informatique pour déterminer des paramètres d'état hémodynamique au moyen de signaux dérivés d'imagerie multispectrale de circulation et perfusion sanguine
US20160270672A1 (en) * 2015-03-20 2016-09-22 East Carolina University Multi-Spectral Laser Imaging (MSLI) Methods and Systems for Blood Flow and Perfusion Imaging and Quantification
US20170017858A1 (en) * 2015-07-15 2017-01-19 Samsung Electronics Co., Ltd. Laser speckle contrast imaging system, laser speckle contrast imaging method, and apparatus including the laser speckle contrast imaging system
WO2020045015A1 (fr) * 2018-08-28 2020-03-05 ソニー株式会社 Système médical, dispositif de traitement d'informations et méthode de traitement d'informations
US20210321887A1 (en) * 2018-08-28 2021-10-21 Sony Corporation Medical system, information processing apparatus, and information processing method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PENG MIAO ET AL: "High Resolution Cerebral Blood Flow Imaging by Registered Laser Speckle Contrast Analysis", IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, IEEE, USA, vol. 57, no. 5, 1 May 2010 (2010-05-01), pages 1152 - 1157, XP011343226, ISSN: 0018-9294, DOI: 10.1109/TBME.2009.2037434 *

Also Published As

Publication number Publication date
CA3196709A1 (fr) 2022-04-14

Similar Documents

Publication Publication Date Title
US10792492B2 (en) Methods, systems and computer program products for determining physiologic status parameters using signals derived from multispectral blood flow and perfusion imaging
US11278220B2 (en) Determining peripheral oxygen saturation (SpO2) and hemoglobin concentration using multi-spectral laser imaging (MSLI) methods and systems
US11553844B2 (en) Methods, systems and computer program products for calculating MetaKG signals for regions having multiple sets of optical characteristics
EP2956906B1 (fr) Analyse d'images vidéo d'un sujet pour identifier des zones d'images spatiales contenant des variations d'intensité périodiques
Kamshilin et al. Accurate measurement of the pulse wave delay with imaging photoplethysmography
CN105009173B (zh) 用于确定对象的动脉血氧饱和度的设备和方法
JP6219279B2 (ja) バイタルサインのリモートモニタリング
Molinaro et al. Contactless vital signs monitoring from videos recorded with digital cameras: an overview
Alafeef et al. Smartphone-based respiratory rate estimation using photoplethysmographic imaging and discrete wavelet transform
Zhou et al. The noninvasive blood pressure measurement based on facial images processing
Blanik et al. Remote vital parameter monitoring in neonatology–robust, unobtrusive heart rate detection in a realistic clinical scenario
EP3975835A1 (fr) Système de surveillance de paramètres physiologiques
Spicher et al. Initial evaluation of prospective cardiac triggering using photoplethysmography signals recorded with a video camera compared to pulse oximetry and electrocardiography at 7T MRI
CN109497977A (zh) 人体心率和血氧饱和度检测方法和装置
Bousefsaf et al. Peripheral vasomotor activity assessment using a continuous wavelet analysis on webcam photoplethysmographic signals
Blazek et al. Active and passive optical imaging modality for unobtrusive cardiorespiratory monitoring and facial expression assessment
Allado et al. Innovative measurement of routine physiological variables (heart rate, respiratory rate and oxygen saturation) using a remote photoplethysmography imaging system: A prospective comparative trial protocol
Saiko et al. On the feasibility of pulse wave velocity imaging for remote assessment of physiological functions
Bella et al. Monitoring of physiological signs and their impact on the Covid-19 pandemic
Malasinghe et al. A comparative study of common steps in video-based remote heart rate detection methods
Blanik et al. Frequency-selective quantification of skin perfusion behavior during allergic testing using photoplethysmography imaging
WO2022076122A1 (fr) Procédés, systèmes et produits-programmes informatiques pour calculer des signaux métakg pour des régions ayant de multiples ensembles de caractéristiques optiques
Blanik et al. Remote pulse oximetry imaging–fundamentals and applications
van Gastel et al. Simultaneous estimation of arterial and venous oxygen saturation using a camera
Saxena A Non-Contact Based System to Measure SPO2 and Systolic/Diastolic Blood Pressure using Rgb-Nir Camera

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21790671

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3196709

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21790671

Country of ref document: EP

Kind code of ref document: A1